“…PNAs have been reported to be stronger in binding to a complementary DNA or RNA strand due to a lack of electron repulsion from the neutral backbone. − Moreover, PNAs are discriminatory in binding, allowing for high sequence specificity and affinity to a genetic target, and inherently capable of evading degradation by nucleases or proteases. , Unfortunately, the neutrality of the backbone of PNAs limits their incorporation into therapeutic design, as it has been reported that single-stranded PNAs suffer from aggregation in solution. , A way to prevent aggregation was to introduce chirality into the PNA backbone at positions α, β, or γ (Figure ). Modifications yielding αPNA − and γPNA ,, are the most common, greatly reducing its limitations (poor membrane permeability, low aqueous solubility, and ambiguity in RNA binding orientation), , while also exploring a new frontier of preferential preorganization . The αPNA modifications have been assessed, discovering a loss of binding affinity toward the intended genetic target relative to nonmodified PNAs. − On the other hand, γPNA modifications deliver improved binding affinity compared to nonmodified PNAs, ,, but the structure and dynamics of the promising miniature poly(ethylene glycol) (miniPEG)-modified γPNAs have not been studied.…”